You are here

NEOD001

Prothena revives its former lead drug, aiming for a smaller population with more severe cases

Endpoints

Wed, 02/3/21 - 10:59 pm

clinical trials

Prothena’s lead drug NEOD001 just imploded in 2 late-stage studies — and there’s nothing left to salvage

Endpoints

Mon, 04/23/18 - 09:14 am

clinical trials

Today’s Top Biotech Stories: Horizon Pharma, Prothena, and Portola Pharmaceuticals

Motley Fool

Wed, 03/19/14 - 12:01 pm

Portola Pharmaceuticals